LAMEDITECH Co., Ltd.
Lameditech Co., Ltd. develops, manufactures, and sells laser blood samplers and medical devices in South Korea. It offers laser lancing devices under the HandyRay-Lite and HandyRay names; HandyRay-Pro, a professional laser blood collection device for hospitals and medical institutions; CAREVEAM, a device designed for the treatment of various skin diseases with its 308nm excimer light system; and … Read more
Market Cap & Net Worth: LAMEDITECH Co., Ltd. (462510)
LAMEDITECH Co., Ltd. (KQ:462510) has a market capitalization of $29.25 Million (₩42.83 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #26575 globally and #1715 in its home market, demonstrating a 15.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LAMEDITECH Co., Ltd.'s stock price ₩4865.00 by its total outstanding shares 8802965 (8.80 Million).
LAMEDITECH Co., Ltd. Market Cap History: 2024 to 2026
LAMEDITECH Co., Ltd.'s market capitalization history from 2024 to 2026. Data shows change from $49.06 Million to $29.25 Million (-60.39% CAGR).
LAMEDITECH Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LAMEDITECH Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
LAMEDITECH Co., Ltd.'s market cap is 0.01 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $49.06 Million | $6.58 Billion | -$9.48 Billion | 0.01x | N/A |
Competitor Companies of 462510 by Market Capitalization
Companies near LAMEDITECH Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to LAMEDITECH Co., Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
LAMEDITECH Co., Ltd. Historical Marketcap From 2024 to 2026
Between 2024 and today, LAMEDITECH Co., Ltd.'s market cap moved from $49.06 Million to $ 29.25 Million, with a yearly change of -60.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩29.25 Million | -26.18% |
| 2025 | ₩39.62 Million | -19.24% |
| 2024 | ₩49.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of LAMEDITECH Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.25 Million USD |
| MoneyControl | $29.25 Million USD |
| MarketWatch | $29.25 Million USD |
| marketcap.company | $29.25 Million USD |
| Reuters | $29.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.